Product Information
NIFEDIPINE ER 60 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1681 per EA under NDC 67877075858. Its NADAC has been published 218 times since Aug 3, 2022.
FDA first approved this application on Mar 29, 2022. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877075858
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA216067FDA Approved
3/29/2022
TE Code
AB2
On Market Since
3/30/2022
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE ER 60 MG TABLET has been published 218 times since Aug 3, 2022, and over the history we have for it it has declined 16.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1681 per EA |
|---|---|
| All-time high | $0.2005 (Aug 10, 2022) |
| All-time low | $0.0982 (Nov 20, 2024) |
| 52-week high | $0.1764 |
| 52-week low | $0.1369 |
| Median price | $0.1522 |
| Average price | $0.1522 |
| Largest weekly change | -32.2% (Nov 20, 2024) |
| Weeks tracked | 218 |
| Tracking since | Aug 3, 2022 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nifedipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE ER 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE ER 60 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1681 per EA (NDC 67877075858), effective Sep 30, 2026.
How has the price of NIFEDIPINE ER 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE ER 60 MG TABLET has declined 16.2%. It has been tracked across 218 weekly CMS publications since Aug 3, 2022.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE ER 60 MG TABLET?
Since Aug 3, 2022, the NADAC for NIFEDIPINE ER 60 MG TABLET has ranged from a low of $0.0982 (Nov 20, 2024) to a high of $0.2005 (Aug 10, 2022), with a median of $0.1522 per EA.
Are there cheaper alternatives to NIFEDIPINE ER 60 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIFEDIPINE ER 60 MG TABLET, is $0.1550 per EA — about 8% below NIFEDIPINE ER 60 MG TABLET.
Who manufactures NIFEDIPINE ER 60 MG TABLET?
NIFEDIPINE ER 60 MG TABLET (NDC 67877075858) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.